top of page
APRIL 20, 2023
RENATUS WAS SLECTED FOR THE SCALE-UP CHALLENGE LAB PROGRAM
Renatus was selected for the Scale-Up Challenge Lab program by Incheon Startup Park.
Renatus is a pharma company thriving to develop next generation cyclodextrins to provide safe treatment options for patients living with cholesterol-associated diseases. Renatus seeks to provide critical impact in developing translational cyclodextrin therapies and fulfill its vision to protect the world from various cholesterol-associate diseases. For more information, please visit www.renatustx.com
bottom of page